A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia-Reference-Cited by-同舟云学术

A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia

Published:2019-10-02 Issue:3 Volume:371 Page:692-702
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Enomoto Takeshi,Tatara Ayaka,Goda Masao,Nishizato Yohei,Nishigori Kantaro,Kitamura Atsushi,Kamada Mami,Taga Shiori,Hashimoto Takashi,Ikeda Kazuhito,Fujii Yuki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference65 articles.

1. Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP

2. Novel dopamine therapeutics for cognitive deficits in schizophrenia;Arnsten;Biol Psychiatry,2017

3. The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets;Baba;Behav Brain Res,2015

4. Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use

5. Betolngar DB Mota É Fabritius A Nielsen J Hougaard C Christoffersen CT Yang J Kehler J Griesbeck O Castro LRV (2019) Phosphodiesterase 1 bridges glutamate inputs with NO- and dopamine-induced cyclic nucleotide signals in the striatum. Cereb Cortex DOI: 10.1093/cercor/bhz041 [published ahead of print].

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets;Substance Abuse and Rehabilitation;2024-08

2. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

3. Cross-pathway integration of cAMP signals through cGMP and calcium-regulated phosphodiesterases in mouse striatal cholinergic interneurons;2023-10-10

4. Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study;Journal of Translational Medicine;2023-08-21

5. Designing of 2,3-dihydrobenzofuran derivatives as inhibitors of PDE1B using pharmacophore screening, ensemble docking and molecular dynamics approach;Computers in Biology and Medicine;2023-06